StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
NOMD$10.21+0.69%
Fair $10.21+0.0%

NOMD

NOMD

Consumer Defensive / Packaged FoodsNYSE

$10.21

+0.07 (+0.69%)

Fairly Valued+0.0%Fair Value $10.21Fund rank 36/100 · Data gapFallback financials|
SA 36/D
F-Score: 3/9

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 23% · confianza 25%

FCF escenarios

weak_data · normalized FCF $348.4M · quality 73.3/100

Data gap 36/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 83/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

36/100

D

Piotroski

3/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 0unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified.
Thesis & Journal · NOMDLocal privado en este navegador · NOMD
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$1.4B

P/E

9.7x

↓

EV/EBITDA

9.5x

↑

ROE

5.5%

↓

Gross Margin

27.1%

↓

Debt/Equity

0.92

↑
52-Week Range$10
$9$18

TradingView lightweight chart

NOMD price, volumen y niveles de valoración

Último $10.21Periodo -2.8%
Fair value: $10.21

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

+1.0%

FCF CAGR

+3.9%

FCF margin

8.3%

FCF / Net income

1.84x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $3.03B · net income $136.7M · FCF $252.2M

2022-FY → 2025-FY

Gross margin

27.1%-0.6% pts

Operating margin

13.3%-1.1% pts

Net margin

4.5%-4.0% pts

FCF margin

8.3%+0.7% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$3.03B$3.03B$3.10B$3.04B$2.94B
Net Income$136.7M$136.7M$227.1M$192.7M$249.8M
EBITDA$368.7M$368.7M$505.1M$480.5M$492.2M
EPS0.910.911.401.131.43
Gross Margin27.1%27.1%29.6%28.2%27.7%
Operating Margin13.3%13.3%14.7%13.6%14.4%
Net Margin4.5%4.5%7.3%6.3%8.5%
Balance Sheet
Debt/Equity0.920.920.820.830.83
Current Ratio1.061.06———
Cash Flow
Free Cash Flow$252.2M$252.2M$355.1M$348.4M$224.7M
Returns
ROE5.5%5.5%8.5%7.4%9.6%
Valuation
P/E9.729.7211.4415.3612.55
EV/EBITDA9.499.498.659.8010.02
P/B0.610.610.981.151.20
Growth & Yield
Revenue Growth-2.2%-2.2%1.8%3.6%—
EPS Growth-35.0%-35.0%23.9%-21.0%—
Dividend Yield6.7%6.7%———

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%

3Y implied EPS CAGR

-0.1%

fácil

EPS terminal req.

$0.91

Spread vs growth

-34.9%

5Y implied EPS CAGR

3.8%

fácil

EPS terminal req.

$1.10

Spread vs growth

-38.8%

10Y implied EPS CAGR

6.9%

razonable

EPS terminal req.

$1.77

Spread vs growth

-41.9%

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -35.0%

Total return

-35.0%

Start / end P/E

12.5x → 11.2x

EPS bridge

1.40 → 0.91

Residual

+3.6%

EPS growth-35.0%
Multiple rerating-10.2%
Dividend+6.7%
Residual / FX / buybacks / cross-term+3.6%

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.